Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Intraocular Lymphoma × pomalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 51 Recurrence 13 Neoplasms, Plasma Cell 9 Primary Myelofibrosis 3 Polycythemia Vera 3 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Myeloproliferative Disorders 2 Hematologic Diseases 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Sarcoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Rituximab 9 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 fludarabine phosphate 6 Cyclophosphamide 6 Etoposide 5 Tacrolimus 4 Mycophenolic Acid 4 Cyclosporine 4 Carboplatin 4 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Thiotepa 2 Melphalan 2 Lenalidomide 2 Ipilimumab 2 Dexamethasone 2 Calcium Dobesilate 2 CTLA-4 Antigen 2 Bendamustine Hydrochloride 2 Antilymphocyte Serum 2 veliparib 1 sodium thiosulfate 1 pegfilgrastim 1 oblimersen 1 merphos 1 etoposide phosphate 1 Vorinostat 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡